XML 13 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Unaudited Interim Statements of Cash Flows
€ in Thousands, $ in Thousands
 6 Months Ended 12 Months Ended
Jun. 30, 2022
EUR (€)
Jun. 30, 2022
USD ($)
 [1]
Jun. 30, 2021
EUR (€)
Dec. 31, 2021
EUR (€)
Cash flows from operating activities        
Loss for the period € (635) $ (660) € (5,162) [2] € (19,640) [2]
Adjustments for:        
Financing expenses, net 2,181 2,267 6,138 26,884
Profit from settlement of derivatives contract 0 0 (407) (407)
Depreciation and amortization 7,978 8,289 7,076 [2] 15,116 [2]
Share-based payment transactions 60 62 13 63
Share of losses (profits) of equity accounted investees 602 625 772 (117)
Payment of interest on loan by an equity accounted investee 0 0 859 859
Change in trade receivables and other receivables (2,579) (2,680) (2,124) (1,883)
Change in other assets 53 55 (782) (545)
Change in receivables from concessions project (550) (571) 757 1,580
Change in trade payables (801) (832) (941) 154
Change in other payables 7,878 8,185 3,715 2,380
Income tax expense (tax benefit) 1,087 1,129 306 [2] (2,281) [2]
Income taxes paid (3,255) (3,382) (15) (94)
Interest received 922 958 921 1,844
Interest paid (4,924) (5,116) (3,857) (7,801)
Net cash provided by operating activities 8,017 8,329 7,269 16,112
Cash flows from investing activities        
Acquisition of fixed assets (22,274) (23,142) (64,665) (83,682)
Repayment of loan by an equity accounted investee 149 155 1,400 1,400
Loan to an equity accounted investee 0 0 (244) (335)
Advances on account of investments 0 0 (8) 0
Settlement of derivatives contract (528) (549) (252) (976)
Investment in restricted cash, net (8,241) (8,562) (185) (5,990)
Proceeds from (investment in) short term deposit 27,645 28,722 8,533 (18,599)
Proceeds from (investment in) marketable securities 0 0 1,785 (112)
Net cash used in investing activities (3,249) (3,376) (53,636) (108,294)
Cash flows from financing activities        
Sale of shares in subsidiaries to non-controlling interests 0 0 1,400 1,400
Proceeds from options 0 0 22 49
Cost associated with long term loans (8,958) (9,307) (197) (2,796)
Payment of principal of lease liabilities (4,000) (4,156) 0 (4,803)
Proceeds from long term loans 196,189 203,835 32,476 32,947
Repayment of long-term loans (143,095) (148,672) (3,390) (18,905)
Repayment of Debentures (19,764) (20,534) (30,730) (30,730)
Repayment of SWAP instrument associated with long term loans (3,290) (3,418) 0 0
Proceeds from issue of convertible debentures 0 0 15,571 15,571
Proceeds from issuance of Debentures, net 0 0 25,465 57,717
Issuance / exercise of warrants 0 0 3,675 3,746
Net cash provided by financing activities 17,082 17,748 44,292 54,196
Effect of exchange rate fluctuations on cash and cash equivalents (3,128) (3,250) 2,489 12,370
Increase (decrease) in cash and cash equivalents 18,722 19,451 414 (25,616)
Cash and cash equivalents at the beginning of the period 41,229 42,836 66,845 66,845
Cash and cash equivalents at the end of the period € 59,951 $ 62,287 € 67,259 € 41,229
[1] * Convenience translation into US$ (exchange rate as at June 30, 2022: EUR 1 = US$1.039)
[2] Reclassified, please see Note 2C.